FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...
From truckloads of torn documents to avian incursions in the production plant, Granules India’s recent manufacturing ...
The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...
Last week, Zydus Lifesciences confirmed the receipt of an FDA warning letter at its Waghodia plant in Gujarat, India, marking ...
A team comprising lead experts from WHO's headquarters in Geneva, India office, and drug regulators from other nations ...
The other highlight of the Modi-Biden meeting was India’s accession to the Clean Economy and Fair Economy agreements of the ...
The Border Security Force (BSF) and Punjab Police recovered a drone with 2kg heroin in Gurdaspur district on Sunday.
Ozempic helps with weight loss by activating GLP-1 receptors to reduce hunger. High-protein and fiber-rich foods like ...
Shares of Bicara Therapeutics—a biopharmaceutical company backed by Indian billionaire Kiran Mazumdar-Shaw—surged about 42% ...
Indian Patent Office to hear objections against Gilead's Lenacapavir patent claims, crucial for affordable HIV treatment ...
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...
India. And when confronted by the FDA inspectors, the plant management acknowledged the papers should not have been destroyed. In describing the episode, the FDA inspectors noted that the quality ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback